NCT00005014View on ClinicalTrials.gov

Treatment of Autism in Children and Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

October 31, 1997

Study Completion Date

February 28, 2001

Conditions
Autistic Disorder
Interventions
DRUG

Risperidone

Trial Locations (5)

21231

Kennedy Krieger Institute, Baltimore

43210

Ohio State Univ, Columbus

46202

Indiana Univ / Riley Hosp for Children, Indianapolis

90024

UCLA, Los Angeles

06520

Yale Univ, New Haven

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT00005014 - Treatment of Autism in Children and Adolescents | Biotech Hunter | Biotech Hunter